Anthony Man

PKC412--a protein kinase inhibitor with a broad therapeutic potential.

D Fabbro, Stephan Ruetz, Stephan Bodis et al. · PubMed · 2000 · 270 citations

Medicine, Oncology, Pharmacology +15

Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers

Anne Schmitt‐Hoffmann, Brigitte Roos, Michael Schleimer et al. · Antimicrobial Agents and Chemotherapy · 2004 · 101 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Multiple-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers

Anne Schmitt‐Hoffmann, Lars Nyman, Brigitte Roos et al. · Antimicrobial Agents and Chemotherapy · 2004 · 78 citations

Medicine, Pharmacokinetics, Pharmacology +12

Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.

K. Ganeshaguru, R G Wickremasinghe, Dylan T. Jones et al. · PubMed · 2002 · 52 citations

Medicine, Oncology, Pharmacology +9

The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients.

Parames Thavasu, David Propper, Alexander McDonald et al. · PubMed · 1999 · 51 citations

Life Sciences, Oncology, Pharmacology +14